Dampak Terapi Sitikolin, Sosiodemografi dan Komorbiditas Terhadap Nilai GCS Pasien Stroke di RSUP dr. M. Djamil Padang

  • Rahmad Abdillah
  • Armenia Armenia
  • Kusnandar Anggadireja

Abstract

Assessment level of consciousness is an important part of clinical neurologic assessment in handling stroke, decrease in consciousness may aggravate prognosis and one of the mortality factors in stroke patients. This study examined the impact of citicoline, sociodemographic characteristics (gender, age, and occupation), and comorbidity on Glasgow Coma Scale (GCS) in stroke patients. Total amount of 82 stroke patients were participated in this study. Between all sociodemographic factors only age and occupation significantly affected GCS (p<0.05). There was no significant impact between dose of citicoline and comorbidity to GCS (p>0,1). We found a significant impact of interaction among type of stroke, dose of citicoline, recurrent stroke, and comorbidity, on GCS (p<0.05). This indicates that there are several factors contributing to the score GCS in this research.

References

Bullock R, Chesnut R, Ghajar J, et al. Guidelines for the management of traumatic brain injury. J. Neurotama. 2000; 17: 448-554.

Dávalos A, Castillo J, Alvarez-Sabín J, Secades JJ, Mercadal J, López S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R . 2002, Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials, Stroke. Dec; 33(12):2850-2857

Depkes. 2011. 8 dari 1000 Orang Di Indonesia Terkena Stroke. Kamis, 6 Oktober 2011. http://www.depkes.go.id/index.php/berita/press-release/1703-8-dari-1000-orang-di-indonesia-terkena-stroke.html. Diakses tanggal 26 Januari 2012.

Di Carlo, A., Lamassa, M., Baldereschi, M., Pracucci, G., Basile, A.M., & Wolfe, C.D. 2003. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke.34, 1114–1119.

Dostovic, Zikrija, Ernestina Dostovi, and C Omer. “Stroke and Disorders of Consciousness Cardiovascular Psychiatry and Neurology (2012): 1-4.

Ginsberg, Myron D.2008, Neuroprotection for ischemic stroke: Past, present, and Future, NIH Journal.Vol 55(3), pp 363-389Gobert JG, Baltes EL. Availability and plasma clearance of piracetam in man. Farmaco 1977;3:84–91.

Gofir, Abdul. 2009, Manajemen Stroke Evidence Based Medicine, Yogyakarta: Pustaka Cendekia Press.

Gokkaya, N. K., Aras, M. D., & Cakci, A. 2005. Health-related quality of life of Turkish stroke survivors. International Journal of Rehabilitation Research 28(3), 229-235

Goldstein, L.B., Bushnell, C.D., Adams, R.J. Appel, L.J., Braun, L.T., Chaturvedi, S., Creager, M.A., Culebras, A., Eckel, R.H., Hart, R.G., Hinchey, J.A., Howard, V.J., Jauch, E.C., Levine, S.R., Meschia, J.F., Moore, W.S., Nixon, J.V.I., & Pearson, T.A. 2011. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 42, 517-584.

Goldstein, L.B., Bushnell, C.D., Adams, R.J. Appel, L.J., Braun, L.T., Chaturvedi, S., Creager, M.A., Culebras, A., Eckel, R.H., Hart, R.G., Hinchey, J.A., Howard, V.J., Jauch, E.C., Levine, S.R., Meschia, J.F., Moore, W.S., Nixon, J.V.I., & Pearson, T.A. 2011. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 42, 517-584.

Helgason, C. M. & Wolf, P.A. 1997. American Heart Association Prevention Conference IV. Prevention and rehabilitation of stroke. Circulation 96, 701–707.

Horne, R. 2001. Compliance, Adherence, and Concordance. Dalam Taylor, K., Kevin, G. Pharmacy Practice. London: Taylor&Francis.

Howard G, Waller MD, Becker C, Coull C, Feibel S, Leroy MK, et al. Community based stroke programs: North Caroline, Oregon and New York. Factor influencing survival after stroke: proportional hazard analysis of 4219 patients. Stroke. 1986;17 : 294 -9.

Jin, J., Sklar, G.E., Min, S. O. V., & Chuen, L. S. 2008. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag.13(1), 269–286.

Kapral MK, Fang J, Hill MD, Silver F, Richards J, & Jaigobin C.2005. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke.36, 809–814.

Kelso, M.L.; Pauly, J.R. Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury. Prog. Mol. Biol. Transl. Sci. 2011, 98, 85–131.

Markus, H, Pereira, A, & Cloud, G. 2010. Citicoline as Codjuvant Treatment of Cognitive Impairment in Chronic Degenerative Central Nervous System Disease and in Ischemic Stroke: A Review Of Available Stroke Medicine, New York: Oxford University Press.

Naing, L, Winn, T, & Rusli, BN. 2006. Practical Issues in Calculating the Sample Size for Prevalence Studies. Archives of Orofacial Sciences, 1, 9-14.

Overgaard, K. 2014. The Effects of Citicoline on Acute Ischemic Stroke: A Review. Journal of Stroke and Cerebrovascular Diseases, 23,1764-1769.

Paul, S.L., Sturm, J.W., Dewey, H.M., Donnan, G.A., Macdonell, R.A.L. & Thrift, A.G. 2005. Long-term outcome in the North East Melbourne stroke incidence study: predictor of quality of life at 5 years after stroke. Stroke. 36, 2082-2086.

Sturm, J.W., Donnan, G.A., Dewey, H.M., Macdonell, R. A., Gilligan, A. K., Srikanth, V., & Thrift, A. G. 2004. Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 35, 2340–2345.

Teasdale G, Jennet B. Assesment of coma and impaired consciousness: A practical scale. Lancet 1974; ii: 81-4

Weir, C J, A P J Bradford, and K R Lees. “The Prognostic Value of the Components of the Glasgow Coma Scale Following Acute Stroke.” Q J Med 96 (2003): 67–74.

Wiwit S. (2010). Stroke dan penanganannya: memahami, mencegah, dan mengobati stroke. Jogjakarta : Katahati.
Published
2017-12-27
How to Cite
ABDILLAH, Rahmad; ARMENIA, Armenia; ANGGADIREJA, Kusnandar. Dampak Terapi Sitikolin, Sosiodemografi dan Komorbiditas Terhadap Nilai GCS Pasien Stroke di RSUP dr. M. Djamil Padang. Jurnal Sains dan Teknologi Farmasi, [S.l.], v. 19, n. Supl1, p. s89-s95, dec. 2017. ISSN 2580-5959. Available at: <http://jstf.ffarmasi.unand.ac.id/index.php/jstf/article/view/106>. Date accessed: 26 may 2018.